Igf1R Crispr Knockout Mcf7 Cell Line(Himan) Canada - FDF

Active Substance
Brand Name
Strength
Schedule
Class
Disease
Therapeutic Area
Status
Authorization Company Name
Authorization Company Country
Authorization Date
Last Update : Till Dec 2024